European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

Subcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by cancer patients, nurses and physicians1-5 Tecentriq SC reduces treatment time by approximately 80%, compared with standard IV infusion6 Roche is working closely with national health systems in Europe to ensure patients can access Tecentriq SC as... Read more

Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform

The transformative point of care solution will complement Roche’s centralised diagnostics portfolio across Clinical Chemistry, Immunochemistry, Coagulation and Molecular, and across multiple disease areas LumiraDx’s technology integrates multiple Point of Care tests on a simple to use single instrument and brings more affordable and accessible testing to patients worldwide Under the terms of the agreement,... Read more

Revealing the Detailed Structure of Lipids and Other Biological Compounds, Contributing to the Development of Health Care and the Life SciencesRelease of the OAD-TOF System, the First in the World to Provide Chemical Structural Analysis

Revealing the Detailed Structure of Lipids and Other Biological Compounds, Contributing to the Development of Health Care and the Life SciencesRelease of the OAD-TOF System, the First in the World to Provide Chemical Structural Analysis Read more

Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences

Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences WALTHAM, Mass. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, today announced the formation of a strategic... Read more

Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference

Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2023 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the... Read more

GE CONVENES CEOS, ATHLETES, ENTREPRENEURS, AND EXPERTS FOR FIRST-OF-ITS-KIND LEADERSHIP EVENT

“The Lean Mindset: The Pursuit of Progress” Brings Together Industry Leaders To Discuss The Mindset Shaping The Leaders Of Tomorrow NEW YORK CITY, N.Y. — September 6, 2023 — GE (NYSE:GE) announced “The Lean Mindset: The Pursuit of Progress,” a first-of-its-kind event for industry leaders to unlock strategies for leadership innovation and efficiency. Hosted by... Read more